I would like to invite you to take part in our research study, which is investigating anxiety and depressive symptoms in the Spanish population during the COVID-19 outbreak.

We have an online questionnaire

That takes about 30 min to complete. We also ask that you please share this with all your networks, friends and family accross Spain. We greatly appreciate your assistance. Below is the invitation email which you could use to forward via email invitation.


Last Publications


libro personas mayores

A Practice Primer

English Version

May 2019


Vol.9 Sistema Dopaminérgico y Trastornos Psiquiátricos

Vol.10 Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

June 2013

ISBN: 978-1-4614-7263-6

Next Course

November, 11th and 12th 2019

XIII Intensive Theoretical-Practical Course of update in Electroconvulsive Therapy

More information

Last Meeting

June, 20th-21th 2014

"Relevance of Staging Psychotic disorders as a Paradigm-shift for understanding disease progression and stage-dependent treatment"

More information


Vol.1 Depressive, Anxiety, and Drug Abuse Disorders

Vol.1 Depressive, Anxiety, and Drug Abuse Disorders

June 1994

Editors: Tomás Palomo, Trevor Archer

Publisher: Editorial Complutense, Donoso Cortés, 65, 28015 MADRID

ISBN: 84-7491-503-1

Pages: 485

More information

Also found within the publications are contributions presented at the meeting held in Madrid in 1992.

Table of contents

Depressive Disorders

  1. Effects of Serotonergic Drugs on Depression Models. G. Curzon
  2. Antidepressant Drug Screens and the Serotonergic System. G.J.Marek and L.S. Seiden
  3. Behavioural Despair Test. F. Borsini
  4. Learned helplessness: an Animal Model of Depression ?. A.V.Christensen
  5. An Integrative Hypothesis of Limbic Multitransmitter Action ofAntidepressive Treatment. W. Kostowski and A. Plaznik
  6. Genetic Differences in Coping with the Environment as a Strategy,rather than Liability, for Studying CNS-active Compounds. P.Driscoll
  7. Early Stimulation and Perinatal Flumazenil Effects on Behavior of theRoman Rat Lines: overcoming a genetically-related deficit. A.Fernández-Teruel, R.M. Escorihuela, P. Driscoll, P. Ferréand A. Tobeña
  8. A Comparative Study of the Biochemical Parameters of the GABAergicand Dopaminergic Neurotransmission in the Brain of Roman HighAvoidance and Roman Low Avoidance Rats. 0. Giorgi,M. Orlandi, D. Lecca, R. Loi, R.M. Escorihuela and M.G. Corda
  9. Psychobiogenetics: genetic studies of the coupling betweenbehavioural and neuroendocrine traits of emotional reactivity. P.Mormède and N. Castanon
  10. Tinnitus, Pain and Affective Disorders. S.I. Erlandsson and T.Archer

Anxiety and Aggression Disorders

  1. Ethologícal Approaches to the Preclinical Psychopharmacologyof Anxiety. R.J. Blanchard, R.J. Rodgers and D.C. Blanchard
  2. Drugs, Neurotransmitters and Offensive Aggression. B. Olivier, J.Mos and R. van Oorschot
  3. Conflict Procedures as Pharmacological Screens for Anxiolytic Drugs. J.E. Barrett and J. Willetts
  4. Is Anxiety Associated with a Hyper- or Hypo-serotoninergic state?. M.Briley and Ph. Chopin
  5. Testing 5-HT Theories of Anxiety in Normal Volunteers. J.F.W.Deakin, F.S. Guimâraes and F.G. Graeff
  6. The Role of Different Serotonin Receptor Subtypes in PsychiatricSyndromes. J. del Río and B.Lasheras
  7. 5-HT Receptor Types and Anxiety. N.R. Oakley, G.J. Kilpatrick andM.B. Tyers
  8. Why do we need new Anxiolytics?. M.H. Lader

Drug Abuse and Reward

  1. Drug Discrimination as a Model for Studying Opioid Dependence andWithdrawal in Animals. C.P. France
  2. Methods to Analyze Individual Vulnerability to Drugs of Abuse. M.S.Hooks and P. W. Kalivas
  3. The Interactions between Opioids and Psychomotor Stimulants. P.Nencini
  4. Studies of Behavioral Dependence. A.M. Young
  5. Dependence Aspects of Anxiolytic Drugs. M.H. Lader
  6. Ontogenic and Adult Changes in the Activity of Hypothalamic andExtrahypothalamic Dopaminergic Neurons after Perinatal CannabinoidExposure in rats. JJ. Fernández-Ruiz, A. Bonnin, M. Cebeiraand J. A. Ramos
  7. Behavioural Pharmacology of Taste Hedonics: a model of studyingnatural rewards and its relevance to the study of drug abuse. S.J.Cooper
  8. Dopaminergic Agents with Different Mechanisms of ActionDifferentially Affect Responding for Conditioned Reward. R.Beninger and R. Ranaldi
  9. Motivational Measures of Drug Dependence. A. Markou, F. Weiss andG.F. Koob
  10. An Animal Model of Alcoholism Developed in the Male Rat. G.Wahlström
  11. Adrenal Corticosteroids Modulate the Consumption of Ethanol in theRat. S. Hansen, C. Fahlke, E. Hard and J.A. Engel

Fundación Cerebro y Mente
c/ General Oraa, 47 - 1º E 28006 Madrid, España
Telf: +34 91 561 1267 Fax: +34 91 564 1817

Resolución mínima: 1024 x 768. Navegadores recomendados: Google Chrome / Firefox 3.5+ / Internet Explorer 9.0+ / Opera 9.0+ / Safari 3.0+